More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy-Reference-Cited by-同舟云学术

More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

Published:2017-01-17 Issue: Volume: Page:kew470
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Tiniakou Eleni,Pinal-Fernandez Iago,Lloyd Thomas E.,Albayda Jemima,Paik Julie,Werner Jessie L.,Parks Cassie A.,Casciola-Rosen Livia,Christopher-Stine Lisa,Mammen Andrew L.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/56/5/787/13756906/kew470.pdf

Reference20 articles.

1. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

2. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

3. Statin-associated autoimmune myopathy;Mammen;N Engl J Med,2016

4. Anti-HMG-CoA reductase antibodies are rare in statin users, including those with self-limited musculoskeletal side-effects;Mammen;Arthritis Care Res,2011

5. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy;Neurology Neuroimmunology & Neuroinflammation;2024-09

2. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments;Journal of Autoimmunity;2024-09

3. Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues;Frontiers in Immunology;2024-08-30

4. Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy;2024-08-28

5. Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical–serological–pathological classification;Rheumatology;2024-07-19